{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T04:41:53Z","timestamp":1784522513344,"version":"3.55.0"},"reference-count":10,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"4","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":255,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>To achieve the nationwide goal of reducing opioid-related deaths, a clinical pharmacy specialist\u2013led clinical video telehealth (CVT) clinic was created at a Veterans Affairs medical center (VAMC) to deliver opioid overdose prevention and naloxone education to at-risk patients. The purpose of this innovative practice was to improve access to this potentially life-saving intervention to patients across urban and rural areas. This study is a single-center, descriptive analysis of adult patients across 2 VAMC campuses and 4 community-based outpatient clinics from July 11, 2016, through December 31, 2016. The purpose of this innovative practice was to increase access to overdose education and naloxone distribution (OEND) to at-risk patients across urban and rural areas. Patient-specific factors were also examined among those receiving naloxone through the CVT clinic compared to other prescribers. During the first 6 months from the initiation of the clinic, 1 pharmacist prescribed 21% of the health care system's naloxone. These patients identified by the pharmacist-led CVT clinic were more likely to be considered high-risk due to concomitant use of opioids and benzodiazepines. In conclusion, the pharmacist-led CVT group clinic has been an efficient strategy to extend OEND services to high-risk patients beyond central, urban areas.<\/jats:p>","DOI":"10.9740\/mhc.2019.07.294","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T17:05:00Z","timestamp":1562000700000},"page":"294-297","source":"Crossref","is-referenced-by-count":12,"title":["Description of a pharmacist-led clinical video telehealth group clinic for opioid overdose prevention and naloxone education"],"prefix":"10.9740","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-7347","authenticated-orcid":false,"given":"Aimee N.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7567-3563","authenticated-orcid":false,"given":"Candace M.","family":"Beam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-1941","authenticated-orcid":false,"given":"Amber R.","family":"Douglass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3090-3924","authenticated-orcid":false,"given":"Jennifer E.","family":"Brabson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5718-5013","authenticated-orcid":false,"given":"Michelle","family":"Colvard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-758X","authenticated-orcid":false,"given":"Jennifer","family":"Bean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4719","reference":[{"key":"2020060307360700100_i2168-9709-9-4-294-b01","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System, Mortality File; 2015. Multiple causes of death, 1993-2013 query [cited 2016 Sep]. Atlanta: Centers for Disease Control and Prevention. Available from: http:\/\/wonder.cdc.gov\/mcd-icd10.html"},{"issue":"1","key":"2020060307360700100_i2168-9709-9-4-294-b02","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/08897077.2015.1129528","article-title":"Patient perspectives on an opioid overdose education and naloxone distribution program in the US Department of Veterans Affairs","volume":"37","author":"Oliva","year":"2016","journal-title":"Subst Abus"},{"issue":"23","key":"2020060307360700100_i2168-9709-9-4-294-b03","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"2020060307360700100_i2168-9709-9-4-294-b04","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/ADM.0000000000000223","article-title":"Prescribe to prevent","volume":"10","author":"Lim","year":"2016","journal-title":"J Addict Med"},{"key":"2020060307360700100_i2168-9709-9-4-294-b05","article-title":"Naloxone kits and naloxone autoinjectors: recommendations for issuing naloxone kits and naloxone autoinjectors for the VA Overdose Education and Naloxone Distribution","author":"VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives in collaboration with the VA OEND National Support and Development Work Group","journal-title":"(OEND) programs, October 2015 [cited 2016 Sep]"},{"issue":"8","key":"2020060307360700100_i2168-9709-9-4-294-b06","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/pme.12777","article-title":"Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in veterans' health administration patients","volume":"16","author":"Zedler","year":"2015","journal-title":"Pain Med"},{"key":"2020060307360700100_i2168-9709-9-4-294-b07","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"2020060307360700100_i2168-9709-9-4-294-b08","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/aje\/kwr318","article-title":"Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study","volume":"175","author":"Evans","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2020060307360700100_i2168-9709-9-4-294-b09","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1360-0443.2008.02182.x","article-title":"Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States","volume":"103","author":"Green","year":"2008","journal-title":"Addiction"},{"issue":"2","key":"2020060307360700100_i2168-9709-9-4-294-b10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.drugpo.2008.03.002","article-title":"Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives","volume":"20","author":"Tobin","year":"2009","journal-title":"Int J Drug Policy"}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/9\/4\/294\/2427708\/mhc_2019_07_294.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/9\/4\/294\/2427708\/mhc_2019_07_294.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T16:25:58Z","timestamp":1731687958000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/9\/4\/article-p294.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2019.07.294","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]}}}